Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 June 2019 | Story Ruan Bruwer
Louzanne Coetzee
Athlete Louzanne Coetzee with the trophy of the Free State Sports Association for the Physically Disabled as Sports Star of the Year.

Although challenging, very exciting and a new journey, says Louzanne Coetzee about the athletics year for which she has been recognised.

The 26-year-old, who is doing her master’s in Social Cohesion and Reconciliation Studies at the University of the Free State, won the Free State Sports Association for the Physically Disabled (FSSAPD) Sports Star of the Year award for a fourth consecutive time. This was for the period June 2018 to April 2019.

In that time, she set a world record, an Africa record, and ran two marathons in which she came amazingly close to a second world record.

Only in her second marathon at the Berlin Marathon in September, the Paralympian fell 26 seconds short of the T11 (totally blind) world record time. She met the qualifying time for the 2020 Paralympic Games in Tokyo during the London Marathon in April.

“Marathons are definitely challenging and a new field for me, but I would say it has been a good 12 months. My aim is now set on next year’s Paralympic Games, where I would like to compete in the marathon and the 1 500 m.”

“I hope to run a good time in the 1 500 m at the World Para Athletics Championships in November.”

At the SASAPD National Championships for physically disabled and visually impaired athletes in April 2019, Coetzee won three gold medals and set a record in the 1 500 m. 

Others from the UFS also honoured

Coetzee has received several awards in her career, but says it is always special to be rewarded by her own federation (FSSAPD). 

Danie Breitenbach (T11) was also honoured as the Senior Male Sports Star. He bagged two gold medals and one silver and set a SA record in both the 800 m and 1 500 m at the nationals. Another Kovsie, Dineo Mokhosoa (F36 – coordination impairments), received a merit award for her gold medal in shot-put and silver in the discus at the national champs.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept